The review will examine ways to improve the transparency of such measures and to avoid related market access delays, in particular for generic medicines.
Tienes una paga regular, y tienes un competidor con quien entrenarEurLex-2 EurLex-2
Option 5: Revision of the directive to improve market access delays for originator products || · Originator companies: earlier return on investment with potentially positive effects on research and innovation.
Voy a cantar una canción.# Para el cumpleaños de nuestra Natalia PetrovnaEurLex-2 EurLex-2
This feature implies that disconnections between pricing and reimbursement decisions for the medicinal product and for the associated diagnostic/medical device might result in trade barriers and market access delays.
Siéntense y les traeremos las copasEurLex-2 EurLex-2
Furthermore, more transparency and better coordination between Member State pricing and reimbursement systems would help avoid unnecessary market access delays and improve the functioning of the internal market for medicine.